Kingsview Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.6M | Sell |
71,619
-211
| -0.3% | -$46.8K | 0.21% | 92 |
|
|
2025
Q4 | $16.4M | Buy |
71,830
+883
| +1% | +$201K | 0.24% | 80 |
|
|
2025
Q3 | $16.4M | Buy |
70,947
+824
| +1% | +$168K | 0.25% | 73 |
|
|
2025
Q2 | $13M | Buy |
70,123
+1,434
| +2% | +$267K | 0.22% | 82 |
|
|
2025
Q1 | $14.4M | Buy |
68,689
+87
| +0.1% | +$16.9K | 0.27% | 64 |
|
|
2024
Q4 | $12.2M | Sell |
68,602
-5,499
| -7% | -$1.01M | 0.24% | 77 |
|
|
2024
Q3 | $14.6M | Buy |
74,101
+2,272
| +3% | +$424K | 0.31% | 56 |
|
|
2024
Q2 | $12.3M | Buy |
71,829
+9,185
| +15% | +$1.52M | 0.29% | 66 |
|
|
2024
Q1 | $11.4M | Sell |
62,644
-39,894
| -39% | -$6.88M | 0.29% | 69 |
|
|
2023
Q4 | $15.9M | Sell |
102,538
-2,101
| -2% | -$306K | 0.47% | 44 |
|
|
2023
Q3 | $15.6M | Buy |
104,639
+28,071
| +37% | +$4.12M | 0.56% | 33 |
|
|
2023
Q2 | $10.3M | Sell |
76,568
-4,962
| -6% | -$728K | 0.4% | 49 |
|
|
2023
Q1 | $13M | Sell |
81,530
-6,931
| -8% | -$1.06M | 0.55% | 34 |
|
|
2022
Q4 | $14.3M | Sell |
88,461
-5,783
| -6% | -$887K | 0.62% | 29 |
|
|
2022
Q3 | $12.6M | Sell |
94,244
-2,682
| -3% | -$385K | 0.6% | 31 |
|
|
2022
Q2 | $14.8M | Buy |
96,926
+14,898
| +18% | +$2.28M | 0.71% | 19 |
|
|
2022
Q1 | $13.3M | Buy |
82,028
+3,517
| +4% | +$511K | 0.59% | 30 |
|
|
2021
Q4 | $10.6M | Buy |
78,511
+1,201
| +2% | +$142K | 0.44% | 44 |
|
|
2021
Q3 | $8.34M | Buy |
77,310
+10,145
| +15% | +$1.16M | 0.4% | 49 |
|
|
2021
Q2 | $7.67M | Buy |
67,165
+17,952
| +36% | +$2.02M | 0.38% | 50 |
|
|
2021
Q1 | $5.34M | Buy |
49,213
+5,660
| +13% | +$605K | 0.3% | 71 |
|
|
2020
Q4 | $4.67M | Buy |
43,553
+4,843
| +13% | +$465K | 0.34% | 67 |
|
|
2020
Q3 | $3.39M | Buy |
38,710
+6,363
| +20% | +$599K | 0.3% | 82 |
|
|
2020
Q2 | $3.18M | Buy |
32,347
+4,758
| +17% | +$419K | 0.32% | 81 |
|
|
2020
Q1 | $2.1M | Buy |
27,589
+10,260
| +59% | +$874K | 0.28% | 96 |
|
|
2019
Q4 | $1.53M | Buy |
17,329
+7,242
| +72% | +$601K | 0.19% | 149 |
|
|
2019
Q3 | $764K | Sell |
10,087
-6,684
| -40% | -$458K | 0.12% | 185 |
|
|
2019
Q2 | $1.22M | Sell |
16,771
-2,527
| -13% | -$199K | 0.2% | 128 |
|
|
2019
Q1 | $1.55M | Sell |
19,298
-24,342
| -56% | -$1.99M | 0.24% | 121 |
|
|
2018
Q4 | $4.02M | Buy |
43,640
+580
| +1% | +$51K | 0.88% | 23 |
|
|
2018
Q3 | $4.07M | Buy |
43,060
+868
| +2% | +$82.3K | 0.83% | 27 |
|
|
2018
Q2 | $3.91M | Sell |
42,192
-454
| -1% | -$44.3K | 0.93% | 22 |
|
|
2018
Q1 | $4.04M | Buy |
42,646
+36,201
| +562% | +$3.98M | 1% | 18 |
|
|
2017
Q4 | $623K | Sell |
6,445
-22
| -0.3% | -$2.07K | 0.22% | 141 |
|
|
2017
Q3 | $575K | Buy |
6,467
+2,241
| +53% | +$171K | 0.25% | 125 |
|
|
2017
Q2 | $306K | Buy |
4,226
+581
| +16% | +$39.1K | 0.16% | 180 |
|
|
2017
Q1 | $238K | Buy |
+3,645
| New | +$229K | 0.14% | 199 |
|
Other funds holding ABBV
VCM
VPM
Kingsview Wealth Management's ABBV Position: Q1 2026 in Review
Kingsview Wealth Management reduced its AbbVie (ABBV) stake by 0.29% in Q1 2026, selling an estimated $46.8K and leaving 71,619 shares worth $15.6M. The position accounts for 0.21% of the portfolio, ranked #92.
Kingsview Wealth Management first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $16.4M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Kingsview Wealth Management held 71,619 shares of AbbVie worth $15.6M as of Q1 2026.
- Kingsview Wealth Management sold 211 AbbVie shares in Q1 2026, an estimated $46.8K.
- AbbVie made up 0.21% of Kingsview Wealth Management's portfolio in Q1 2026, its #92 holding.
- Kingsview Wealth Management first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Kingsview Wealth Management's AbbVie position peaked at $16.4M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.